Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Halozyme Therapeutics, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Halozyme Therapeutics, Inc.

H. Michael Shepard, Ph.D., has joined Halozyme Therapeutics as vice president, discovery research.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

H. Michael Shepard, Ph.D., has joined Halozyme Therapeutics as vice president, discovery research. Dr. Shepard is a recipient of numerous biotechnology patents and scientific awards for his contributions to the development of innovative therapies. He has more than 25 years of experience in the biotechnology industry. At Genentech, Dr. Shepard led the team that discovered the breast cancer drug, Herceptin, which was designed to attack HER2 positive breast cancers. In 2007, Dr. Shepard shared the Warren Alpert Prize from Harvard Medical School in recognition of this achievement.

Dr. Shepard also built successful programs at various biotechnology companies in areas including antibiotics, cancer gene therapy and receptor fusion proteins. He served as chief scientific officer of Canji, Inc. and, most recently, founder and president of Receptor BioLogix, Inc.

“We are delighted to have Dr. Shepard’s discovery research leadership at Halozyme,” said Gregory Frost, Ph.D., Halozyme’s chief scientific officer. “Mike’s ability to translate his broad scientific understanding into innovative biologics complements the research and development team at Halozyme as we build a world class biopharmaceutical organization.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters